Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

In re Pradaxa (Dabigatran Etexilate) Products Liability Litigation

United States District Court, Seventh Circuit

June 12, 2013

IN RE PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION MDL No. 2385 This Document Relates to: Charles Prichard and Joan Prichard
v.
Boehringer Ingelheim Pharmaceuticlas, Inc. and Boehringer Ingelheim International GmbH No. 3:12-cv-50061-DRH-SCW

ORDER GRANTING SUBSTITUTION

David R. Herndon Chief Judge United States District Court.

Plaintiff Joan Prichard and her counsel, pursuant to F.R.C.P. 25(a), have filed a motion to substitute Plaintiff Joan Prichard for Plaintiff Charles Prichard as a result of the death of Charles Prichard (Doc. 7). Movants’ state that, pursuant to Cal. Civ. Proc. Code §§ 377.20, 377.21 and 377.30, Plaintiff Joan Prichard, as the wife of decedent at all times relevant to this action, has standing to bring this claim as Plaintiff Charles Prichard’s successor in interest, as no estate has been or will be opened, and a personal representative has not and will not be appointed (Doc. 7).

The motion to substitute is GRANTED. Plaintiff Joan Prichard, successor in interest to Charles Prichard, is hereby substituted in as Plaintiff for the Decedent Charles Prichard.

FURTHER, The Court instructs the Clerk of the Court to revise the docket accordingly.

SO ORDERED


Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.